SASKATOON, Saskatchewan, Sept. 03, 2024 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that, further to its news release dated August 22, 2024, it has completed the acquisition of a
About PharmaCorp Rx Inc. Read More